About Us
We believe our people are our greatest asset, and we recognize the boundless potential that comes with a talented and diverse team dedicated to advancing cellular biotechnology to improve health. Our team is fully committed to upholding our legacy of extending life with health.
Biocell Ultravital 24kt GmbH
Lucerne, Switzerland
Integrative Cancer Care, Zurich, Switzerland
Biocell Ultravital, Medical Advisor
For the past eight decades, our core objective has been building on our understanding of the behavior of microscopic life in our bodies. Our fundamental goal is to optimize cellular health, and everything we do aims to achieve this goal. We are committed to developing life-enhancing biotechnological treatments, starting with a preventive, supportive approach to help our body and cells maintain their youth, especially in the later stages of life. At Biocell Ultravital, we are here to assist you in feeling and moving better. Through healthcare professionals, we will provide you with the necessary treatments and up-to-date information to help prolong your life with health.
Mission
The Biocell Ultravital Institute of Biological Research, based in France, reinforces our commitment to enhancing both the life expectancy and quality of all individuals. For decades, we have dedicated immense effort to the research and development of treatments and products to optimize Cellular Nutrition.
The year 2004 marked a significant milestone when we consolidated our research on cellular therapies in Switzerland. Anita Holler, a scientist collaborating with the Swiss Federal Health Office, shared her enthusiasm with The Scientist newspaper, stating, "We are very pleased that the majority of the Swiss population accepted the law on human embryonic stem cells.” This legislative advancement has underscored Switzerland’s reputation as a leading scientific hub, particularly in the field of cellular therapies. It symbolizes a shift from previous scepticism and reluctance, reinforcing Switzerland's historical role as the birthplace of cellular research. For Biocell Ultravital, this new law serves as an official endorsement of all our scientific pursuits.
We are also pleased by the remarks of Dr. William Haseltine in 2003 that “The era of regenerative medicine is upon us.” This statement represents a pivotal transition, as we move from over 40 years of cautious exploration to establishing regenerative cellular medicine as a cornerstone of our clinical research. Dr. Haseltine, a former professor at Harvard Medical School and founder of Human Genome Sciences and other successful biotechnology companies, has been recognized as one of the most influential figures in biotechnology.
It took decades for proponents of conventional synthetic drugs to acknowledge their therapeutic limitations. These drugs often aim to treat diseases by addressing visible symptoms only, overlooking that most diseases stem from underlying cellular defects, especially at the mitochondrial level. The mitochondria not only generate energy for the cells but also regulate cellular aging by maintaining the balance between pro-oxidative free radicals and antioxidant enzymes. At Biocell Ultravital, we categorize these as type 1, 2, and 3 cell disorders. We draw upon the insights of two-time Nobel Laureate Dr. Linus Pauling (1901-1994), who coined the concept of molecular diseases in 1949 to emphasize that almost all organ and tissue disorders arise from cellular structural damage.
In 2009, European and American specialists in gerontology (study of aging) initiated a longitudinal study to follow about 74,000 males and females who reached 80-90 years (octogenarians) across different countries. Nine years later, about 11% of the initial participants survived. After analyzing numerous factors that might contribute to disease development, the researchers confirmed that aging remains the strongest predictor of nearly all diseases in the study participants. Such findings underscore the importance of maintaining functional organs and tissues into old age. Our mission is to help you join the ranks of centenarians (≥100 years old) who live their lives to the fullest, with sharp cognitive abilities and self-independence. Thus, we remain committed to collaborating with the medical community and key opinion leaders to promote and apply Cellular Renewal Therapies for disease prevention and longevity.